T9	Subject 71 100	a 50-year-old female with CHC
T11	Age 73 84	50-year-old
T12	Gender 85 91	female
T13	Sub-Disorder 97 100	CHC
T15	Drug 27 43	interferon alpha
T16	Drug 48 57	ribavirin
T8	Treatment 4 57	combination therapy of interferon alpha and ribavirin
T17	Drug 150 166	interferon alpha
